mTOR inhibition prevents epithelial stem cell senescence and protects from radiation-induced mucositis

Cell Stem Cell. 2012 Sep 7;11(3):401-14. doi: 10.1016/j.stem.2012.06.007.

Abstract

The integrity of the epidermis and mucosal epithelia is highly dependent on resident self-renewing stem cells, which makes them vulnerable to physical and chemical insults compromising the repopulating capacity of the epithelial stem cell compartment. This is frequently the case in cancer patients receiving radiation or chemotherapy, many of whom develop mucositis, a debilitating condition involving painful and deep mucosal ulcerations. Here, we show that inhibiting the mammalian target of rapamycin (mTOR) with rapamycin increases the clonogenic capacity of primary human oral keratinocytes and their resident self-renewing cells by preventing stem cell senescence. This protective effect of rapamycin is mediated by the increase in expression of mitochondrial superoxide dismutase (MnSOD), and the consequent inhibition of ROS formation and oxidative stress. mTOR inhibition also protects from the loss of proliferative basal epithelial stem cells upon ionizing radiation in vivo, thereby preserving the integrity of the oral mucosa and protecting from radiation-induced mucositis.

Publication types

  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Carcinoma, Squamous Cell / enzymology
  • Carcinoma, Squamous Cell / pathology
  • Cell Compartmentation / drug effects
  • Cell Compartmentation / radiation effects
  • Cell Death / drug effects
  • Cell Death / radiation effects
  • Cell Proliferation / drug effects
  • Cell Proliferation / radiation effects
  • Cells, Cultured
  • Cellular Senescence* / drug effects
  • Cellular Senescence* / radiation effects
  • Clone Cells
  • Cytoprotection* / drug effects
  • Cytoprotection* / radiation effects
  • Epithelial Cells / drug effects
  • Epithelial Cells / enzymology
  • Epithelial Cells / pathology*
  • Epithelial Cells / radiation effects
  • Head and Neck Neoplasms / enzymology
  • Head and Neck Neoplasms / pathology
  • Humans
  • Keratinocytes / drug effects
  • Keratinocytes / enzymology
  • Keratinocytes / pathology
  • Keratinocytes / radiation effects
  • Mice
  • Mouth Mucosa / drug effects
  • Mouth Mucosa / pathology
  • Mouth Mucosa / radiation effects
  • Mucositis / enzymology
  • Mucositis / pathology
  • Mucositis / prevention & control*
  • Oxidative Stress / drug effects
  • Oxidative Stress / radiation effects
  • Radiation Injuries / enzymology
  • Radiation Injuries / pathology
  • Radiation Injuries / prevention & control*
  • Radiation, Ionizing
  • Sirolimus / pharmacology
  • Stem Cells / drug effects
  • Stem Cells / enzymology
  • Stem Cells / pathology*
  • Stem Cells / radiation effects
  • Superoxide Dismutase / metabolism
  • TOR Serine-Threonine Kinases / antagonists & inhibitors*
  • TOR Serine-Threonine Kinases / metabolism

Substances

  • Superoxide Dismutase
  • MTOR protein, human
  • TOR Serine-Threonine Kinases
  • Sirolimus